Brainsway Ltd
BWAY
View Detailed Chart
15.590USD
0.000
Close 11/07, 16:00（ET）Quotes delayed by 15 min
589.14MMarket Cap
110.24P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-7.48%
1 Month
+0.42%
6 Months
+75.76%
Year to Date
+65.32%
1 Year
+43.55%
View Detailed Chart
TradingKey Stock Score of Brainsway Ltd
Currency: USD Updated: 2025-11-07Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Brainsway Ltd's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
18.000
Target Price
+15.46%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Brainsway Ltd Highlights
StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 50.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.02M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 107.77, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.59M shares, decreasing 13.67% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 199.83K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.10.
Brainsway Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Brainsway Ltd Info
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOMr. Hadar Levy
Websitehttps://www.brainsway.com/
Related Instruments
+0.82%
+1.13%
+1.14%
+2.23%
-0.35%
+0.98%
+0.63%
+2.38%
+1.11%
+0.42%
+1.06%
+3.20%
+0.13%
-0.74%
+0.25%
+1.15%
+1.25%
-0.51%
+0.74%
-0.40%Popular Symbols
